---
title: "Pfizer’s Hympavzi secures FDA expanded indications for haemophilia"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/289169446.md"
description: "A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser."
datetime: "2026-06-09T09:05:26.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/289169446.md)
  - [en](https://longbridge.com/en/news/289169446.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/289169446.md)
---

# Pfizer’s Hympavzi secures FDA expanded indications for haemophilia

A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser.

### Related Stocks

- [PFE.US](https://longbridge.com/en/quote/PFE.US.md)

## Related News & Research

- [Cerity Partners LLC Buys 1,448,806 Shares of Pfizer Inc. $PFE](https://longbridge.com/en/news/289292675.md)
- [<![CDATA[Chai Discovery Enters License Agreement with Pfizer to Accelerate Drug Discovery with AI]]>](https://longbridge.com/en/news/288873963.md)
- [Pfizer Says FDA Approves Expanded HYMPAVZI Indication For Hemophilia A And B](https://longbridge.com/en/news/289046752.md)
- [Shift in biosimilar commercial landscape essential for sector sustainability, expert says](https://longbridge.com/en/news/289174897.md)
- [Parabilis eyes $475m IPO to push lead asset into Phase III](https://longbridge.com/en/news/288850252.md)